New weight loss drugs could mean a $25 billion drag on restaurants by 2025, says Mizuho's Dan Dolev
Matt Taylor, Jefferies analyst, and Dan Dolev, managing director at Mizuho Securities, join ‘The Exchange’ to discuss how new weight loss drugs could decline revenue for restaurant transaction platforms Toast Tab, and how weight loss…